Clinical trials
Alcoholism clinical trials
Below are recruiting alcoholism clinical trials, each written for real people, not researchers. We’re tracking 564 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05463796Recruiting
Prevention and early detection for people at high cancer risk
This study looks at surveillance (watching closely), prevention, and early “interception” steps to lower the chance that cancer will develop or be found later. It is for people with genetic risk, past cancer treatment exposures, strong family history, or certain early pre-cancer or high-risk conditions.
Boston, MassachusettsAges Any age - NCT05474989RecruitingPhase 2
LSD-assisted therapy for alcohol use disorder
This Phase 2 trial studies whether an LSD treatment approach, combined with study procedures, can help people with moderate-to-severe alcohol use disorder cut down or stop drinking. It may help reset patterns around cravings and drinking, but it also requires careful safety screening.
BaselAges 25 years+ - NCT05480696RecruitingPhase 2
Soluble fiber supplement for fatty liver in kids
This Phase 2 study tests whether a soluble fiber supplement can improve fatty liver disease in children who have obesity and confirmed NAFLD. It may help reduce liver fat and related liver enzyme elevations measured during clinic visits and MRI.
Hamilton, OntarioAges 8–17 - NCT05490589Recruiting
Parenting program for parents affected by alcohol use
This trial tests a structured parenting program for parents of children ages 4 to 12 when the parent (or spouse) has an alcohol use disorder. It may help families by supporting parenting skills and improving day-to-day family functioning.
BrestAges 18 years+ - NCT05613608RecruitingPhase 2/Phase 3
Cannabidiol (CBD) study for alcohol use disorder
This trial tests whether cannabidiol (CBD) can help people cut down or quit drinking alcohol. It enrolls adults diagnosed with alcohol use disorder and wanting to reduce drinking, while checking for safety and other mental health or drug use factors.
Aurora, ColoradoAges 21 years+ - NCT05620849Recruiting
Young adult alcohol health education program study
This study tests an education program about alcohol and health for young adults. It may help you learn safer choices and better understand health effects.
Seattle, WashingtonAges 18–24 - NCT05621538Recruiting
Neurofeedback plus brain stimulation for alcohol use disorder
This trial studies whether combining brain “training” (neurofeedback) with noninvasive brain stimulation (TMS) can help people with alcohol use disorder. It may be offered as an additional treatment alongside care you’re already receiving.
Auburn, AlabamaAges 19–65 - NCT05674409Recruiting
Telehealth family program for moderate to severe alcohol use
This study tests a brief treatment delivered by video that involves a Veteran and a concerned family member or friend. It’s meant for Veterans with ongoing alcohol problems, to see if family involvement helps them change drinking and stay safe during treatment.
Charleston, South CarolinaAges 21 years+ - NCT05684094Recruiting
Study links sleep, stress, and brain reward in risky drinking
This study looks at how sleep timing and stress affect brain responses related to reward and stress in young adults who drink heavily. It may help researchers understand why some people take bigger alcohol risks and how sleep and stress could be part of safer treatment.
Eugene, OregonAges 18–24 - NCT05732207Recruiting
Study of brain changes in alcohol use disorder
This study looks at whether alcohol use disorder affects the cerebellum, a part of the brain involved in movement and balance. It may help researchers understand brain impacts and guide better treatments.
Baltimore, MarylandAges 25–55 - NCT05738174Recruiting
High-dose brain stimulation to help treat alcohol addiction
This trial studies a type of noninvasive brain stimulation to reduce alcohol dependence and help people drink less or stop. You may be offered an accelerated treatment schedule, with regular check-ins and questionnaires to track progress.
RegensburgAges 18–65 - NCT05778734Recruiting
Study to help young adults improve alcohol steadiness
This study is looking at ways to increase “alcohol abstinence,” meaning drinking less or stopping. It focuses on young adults who currently drink and have symptoms of alcohol use disorder, and it may help them build skills to reduce or stop drinking.
Chicago, IllinoisAges 18–24 - NCT05781009RecruitingPhase 2
Pregnenolone treatment for alcohol use disorder
This Phase 2 study tests pregnenolone to help reduce or improve alcohol use disorder symptoms. It looks for adults who drink regularly and meet diagnostic criteria for moderate to severe alcohol use disorder, while excluding people with certain other substance use, medicines, or serious mental/medical conditions.
New Haven, ConnecticutAges 18–70 - NCT05800899Recruiting
Brief counseling program for alcohol-related injuries in Latinxs
This trial tests a culturally tailored, short counseling session for people who are Latinx and have alcohol-related injuries. It aims to reduce health disparities by helping improve treatment access and outcomes after an injury.
El Paso, TexasAges 18 years+ - NCT05807139RecruitingPhase 1
Spironolactone for alcohol use disorder
This Phase 1 study tests whether spironolactone (a medicine that affects salt and hormone balance) is safe and potentially helpful in people with alcohol use disorder. You may be eligible if you are currently drinking heavily, have low alcohol withdrawal symptoms, and meet several lab and medication safety rules.
Baltimore, MarylandAges 21–99 - NCT05854693Recruiting
Direct brain stimulation to reduce alcohol cravings
This study tests whether a noninvasive brain stimulation technique can reduce alcohol cravings in people with alcohol dependence. If you qualify, you may receive sessions aimed at lowering craving, alongside study monitoring for safety.
Taipei, Taipei CITYAges 20–65 - NCT05855668Recruiting
Study how brain and behavior differ in alcohol and cannabis use
This study looks at how people’s thoughts, brain-related measures, and behaviors differ between alcohol use disorder and cannabis use disorder. You may be asked to join group psychotherapy and complete assessments, which could help improve how care is planned for people like you.
Toronto, OntarioAges 18 years+ - NCT05860699RecruitingPhase 2
Cannabidiol added during inpatient alcohol withdrawal
This trial tests whether cannabidiol (CBD) given during an inpatient alcohol detox helps people stay off alcohol afterward. You would be compared with standard care to see if CBD improves recovery during and after withdrawal.
Créteil, Albert ChenevierAges 18–75 - NCT05890365Recruiting
Study risk of fatty liver in low birth weight adults
This study looks at whether being born with low birth weight is linked to a higher chance of non-alcoholic fatty liver disease (fatty liver not caused by heavy drinking). It compares people born with low birth weight to people born with typical birth weight to better understand risk factors.
HerlevAges 34–49 - NCT05899660Recruiting
Omega-3 for alcohol use disorder during withdrawal
This trial studies whether taking omega-3 supplements during a hospital alcohol-withdrawal program can improve recovery for people with alcohol use disorder. It may help by changing inflammation and how the body responds to stopping alcohol.
BrusselsAges 18–70 - NCT05910580Recruiting
Screening and support for alcohol and substance risk in adults
This study aims to improve care access and outcomes for adults who screen positive for risky alcohol or drug use. If you qualify, you may be offered ways to connect to support during your reproductive years.
Boston, MassachusettsAges 18 years+ - NCT05913518Recruiting
Neurofeedback training for people recovering from alcohol use disorder
This study tests whether a brain-training therapy called neurofeedback can improve “metacognition” (how well you monitor and understand your own thinking) in people with severe alcohol use disorder during/after a short detox program. It also studies brain signals using special recordings to see what changes may happen.
BrusselsAges 18–65 - NCT05913752RecruitingPhase 1/Phase 2
Test drug CMND-100 in people with alcohol use disorder
This early study tests the safety and dosing of CMND-100 in first-time participants, including people with alcohol use disorder (AUD) and some healthy volunteers. It may help researchers understand whether the drug is safe, and how it might affect alcohol use in AUD.
New Haven, ConnecticutAges 18–60 - NCT05920629Recruiting
Moderate drinking and heart recovery after a recent heart attack
This study looks at whether moderate alcohol intake affects heart function after a recent heart attack. You may be asked to follow a specific plan and attend scheduled visits so researchers can measure changes in your heart and overall recovery.
Basel, BaselAges 18 years+
Hear when a new Alcoholism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for alcoholism?
- Yes. Clin2 currently lists 564 recruiting alcoholism studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a alcoholism trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a alcoholism trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.